Colchicine for treatment of acute or recurrent pericarditis

The Lancet

Volumn 383, Issue 9936, 2014, Pages 2193-2194

  Cacoub, Patrice P ^a,b,c  

^a Unit of Dermatology   (France)

^b CNRS   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; HUMAN IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CORTICOSTEROID;

ACUTE DISEASE; CORTICOSTEROID THERAPY; DRUG WITHDRAWAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MULTICENTER STUDY (TOPIC); NOTE; PERICARDIECTOMY; PERICARDITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RISK FACTOR; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; AUTOIMMUNE DISEASE; FAMILIAL MEDITERRANEAN FEVER; FEVER; HEART SURGERY; HEART TAMPONADE; LONG TERM CARE; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; PROGNOSIS;

ANTI-INFLAMMATORY AGENTS; COLCHICINE; FEMALE; HUMANS; MALE; PERICARDITIS;

EID: 84903275463     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60113-6     Document Type: Note

References (12)

1. Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation 2007; 115: 2739-44.
2. Maestroni S, Di Corato PR, Cumetti D, et al. Recurrent pericarditis: autoimmune or autoinfl ammatory? Autoimmun Rev 2012; 12: 60-65.
3. Brucato A, Brambilla G, Moreo A, et al. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am J Cardiol 2006; 98: 267-71.
4. Picco P, Brisca G, Traverso F, Loy A, Gattorno M, Martini A. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinfl ammatory disease? Arthritis Rheum 2009; 60: 264-68.
5. Imazio M, Brucato A, Maestroni S, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation 2011; 124: 1270-75.
6. Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circul ation 2005; 112: 2012-16.
7. Cacoub P, Sbaï A, Wechsler B, Amoura Z, Godeau P, Piette JC. Efficacy of colchicine in recurrent acute idiopathic pericarditis. Arch Mal Coeur Vaiss 2000; 93: 1511-14 (in French).
8. Imazio M, Brucato A, Cemin R, et al; ICAP Investigators. A randomized trial of colchicine for acute pericarditis. N Engl J Med 2013; 369: 1522-28.
9. Imazio M, Bobbio M, Cecchi E, et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med 2005; 165: 1987-91.
10. Imazio M, Brucato A, Cemin R, et al; CORP (COlchicine for Recurrent Pericarditis) Investigators. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med 2011; 155: 409-14.
11. Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet 20 14; published online March 30. http://dx.doi.org/10.1016/S0140-6736(13)62709-9.
12. Geri G, Wechsler B, Thi Huong du L, et al. Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature. Medicine (Baltimore) 2012; 91: 25-34.